The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets
Patalganga plant received zero observation from USFDA earlier
Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
The inspection concluded with zero observations, confirming the facility's compliance with current Good Manufacturing Practices
This certification paves the way for CORONA's entry into five EAEU member nations- Russia, Kyrgyzstan, Armenia, Belarus, and Kazakhstan-under a B2B business model
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
These observations are procedural in nature and the company does not anticipate any impact on supply of its commercial products
The Cranbury facility represents a strategic advancement of the company's operations in the Unted States
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
Subscribe To Our Newsletter & Stay Updated
